At a glance
ClinicalIndex Comparison RecordN/ACompleted· 159 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Performance of MRI Prostate in Men With Different Prostate Health Index (Phi) Values: Can we Save Some MRI Scans?
In Brief
An observational study for Prostate Cancer. Completed, enrolled 159 participants across 1 site.
Detailed Summary
This study is to investigate, in a larger cohort of consecutive men, the proportion of abnormal MRI prostate in different phi ranges, and the cancer detected in Chinese men with abnormal MRI. This study aims to evaluate whether MRI prostate can be omitted in men with lower suspicion of prostate cancer.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsProstate Cancer
CountriesHong Kong
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartNov 2021
First PostedJun 2022
Primary CompletionDec 2023
Study CompletionFeb 2024
TodayJul 2026
First PostedJun 30, 2022
Enrollment StartNov 11, 2021
Primary CompletionDec 27, 2023
Study CompletionFeb 1, 2024
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 4.0 years ago